No, pentoxifylline and bromocriptine are completely different medications with distinct mechanisms of action, chemical structures, and clinical uses.
These are two entirely separate drugs that should never be confused or substituted for one another.
Key Differences
Chemical Structure and Drug Class
- Pentoxifylline is a tri-substituted xanthine derivative (methylxanthine) that acts as a hemorrheologic agent, affecting blood viscosity and flow properties 1
- Bromocriptine is a dopamine receptor agonist that activates post-synaptic dopamine receptors 2
Mechanisms of Action
Pentoxifylline works by:
- Decreasing blood viscosity
- Improving erythrocyte flexibility
- Increasing leukocyte deformability
- Enhancing tissue oxygenation in peripheral arterial disease 1
Bromocriptine works by:
- Directly stimulating dopamine receptors
- Inhibiting prolactin secretion
- Modulating motor function in the corpus striatum 2
Clinical Indications
Pentoxifylline has been studied for:
- Claudication in peripheral arterial disease (though NOT recommended per AHA/ACC guidelines due to lack of efficacy) 3
- The 2016 AHA/ACC guidelines give pentoxifylline a Class III: No Benefit recommendation for claudication treatment 3
Bromocriptine is used for:
- Hyperprolactinemia and prolactin-secreting pituitary adenomas
- Parkinson's disease
- Type 2 diabetes (as a dopamine-2 agonist) 4
- Acromegaly 2
Important Clinical Context
While one research study 5 mentioned both drugs in the context of peripartum cardiomyopathy, this does not indicate they are similar medications—they were simply being evaluated for the same rare condition through completely different mechanisms.
Critical Safety Point
Never substitute one medication for the other. They have no overlapping pharmacology, and confusion between these medications could result in treatment failure and patient harm.